{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:34:03Z","timestamp":1790681643853,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":81,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.yrtph.2021.104931","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T11:10:10Z","timestamp":1619262610000},"page":"104931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["New framework for a non-animal approach adequately assures the safety of cosmetic ingredients \u2013 A case study on caffeine"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0497-4094","authenticated-orcid":false,"given":"Dagmar","family":"Bury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Alexander-White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Harvey J.","family":"Clewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6207-4158","authenticated-orcid":false,"given":"Mark","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Desprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Detroyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Efremenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Firman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1045-0748","authenticated-orcid":false,"given":"Nicola J.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6927-8962","authenticated-orcid":false,"given":"Gerry","family":"Kenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Klaric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5695-0986","authenticated-orcid":false,"given":"Cathy","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Mahony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2101-6573","authenticated-orcid":false,"given":"Gladys","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Paini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schepky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2021.104931_bib1","article-title":"A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment. Manuscript submitted to","author":"Alexander-White","year":"2021","journal-title":"Regul. Toxicol. Pharmacol"},{"key":"10.1016\/j.yrtph.2021.104931_bib2","doi-asserted-by":"crossref","first-page":"pp33","DOI":"10.1007\/978-3-642-13443-2_3","article-title":"Pharmacokinetics and metabolism of natural methylxanthines in animal and man","volume":"200","author":"Arnaud","year":"2010","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.yrtph.2021.104931_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.comtox.2017.10.001","article-title":"Ab initio chemical safety assessment: a workflow based on exposure considerations and non-animal methods","volume":"4","author":"Berggren","year":"2017","journal-title":"Comput. Toxicol."},{"issue":"19","key":"10.1016\/j.yrtph.2021.104931_bib4","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1016\/0006-2952(88)90402-9","article-title":"Caffeine and theophylline metabolism in newborn and adult human hepatocytes; comparison with adult rat hepatocytes","volume":"37","author":"Berthou","year":"1988","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.yrtph.2021.104931_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/00498258909042282","article-title":"Comparison of caffeine metabolism by slices, microsomes and hepatocyte cultures from adult human liver","volume":"19","author":"Berthou","year":"1989","journal-title":"Xenobiotica"},{"key":"10.1016\/j.yrtph.2021.104931_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tox.2017.03.012","article-title":"The margin of internal exposure (MOIE) concept for dermal risk assessment based on oral toxicity data \u2013 a case study with caffeine","volume":"392","author":"Bessems","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2021.104931_bib7","series-title":"Caffeine: Perspectives from Recent Research","first-page":"48","article-title":"Interspecies Comparisons of Caffeine Disposition","author":"Bonati","year":"1984"},{"issue":"356","key":"10.1016\/j.yrtph.2021.104931_bib8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/01621459.1976.10480949","article-title":"Science and statistics","volume":"71","author":"Box","year":"1976","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.yrtph.2021.104931_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/bdrb.20288","article-title":"Evaluation of the reproductive and developmental risks of caffeine","volume":"92","author":"Brent","year":"2011","journal-title":"Birth Defects Research (Part B)"},{"issue":"4","key":"10.1016\/j.yrtph.2021.104931_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/074823379701300401","article-title":"Physiological parameter values for physiologically based pharmacokinetic models","volume":"13","author":"Brown","year":"1997","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.yrtph.2021.104931_bib11","first-page":"439","article-title":"Physiologically based pharmacokinetic\/toxicokinetic modeling","volume":"vol. 929","author":"Campbell","year":"2012"},{"key":"10.1016\/j.yrtph.2021.104931_bib12","series-title":"Combining in Vivo, in Vitro and Toxicokinetics Data in Read-Across: A Case Study Using Caffeine","author":"Chavan","year":"2017"},{"key":"10.1016\/j.yrtph.2021.104931_bib13","author":"Cosmetics Ingredient Review (CIR)"},{"key":"10.1016\/j.yrtph.2021.104931_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1539-6924.1994.tb00268.x","article-title":"Sensitivity of physiologically-based pharmacokinetic models to variation in model parameters: methylene chloride","volume":"14","author":"Clewell","year":"1994","journal-title":"Risk Anal."},{"key":"10.1016\/j.yrtph.2021.104931_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.toxlet.2008.06.002","article-title":"On the incorporation of chemical-specific information in risk assessment","volume":"180","author":"Clewell","year":"2008","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2021.104931_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.yrtph.2007.10.012","article-title":"Development and specification of physiologically based pharmacokinetic models for use in risk assessment","volume":"50","author":"Clewell","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.yrtph.2021.104931_bib17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.yrtph.2015.05.012","article-title":"Novel database for exposure to fragrance ingredients in cosmetics and personal care products","volume":"72","author":"Comiskey","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2021.104931_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00734999","article-title":"Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines","volume":"3","author":"Daly","year":"1983","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.yrtph.2021.104931_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00315208","article-title":"Effects of caffeine with repeated dosing","volume":"40","author":"Denaro","year":"1991","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.yrtph.2021.104931_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-5173(99)00067-8","article-title":"Topical delivery of caffeine from some commercial formulations","volume":"182","author":"Dias","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.yrtph.2021.104931_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1467-2494.1998.181621.x","article-title":"O\/W emulsion and W\/O\/W multiple emulsion: physical characterization and Skin pharmacokinetic comparison in the delivery process of caffeine","volume":"20","author":"Doucet","year":"1998","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.yrtph.2021.104931_bib22","series-title":"Read-across Assessment Framework (RAAF) ECHA-17-R-01-EN","author":"ECHA","year":"2017"},{"key":"10.1016\/j.yrtph.2021.104931_bib23","series-title":"Guidance for the Identification of Endocrine Disruptors in the Context of Regulations (EU) No 528\/2012 and (EC) No 1107\/2009","author":"ECHA\/EFSA","year":"2018"},{"issue":"5","key":"10.1016\/j.yrtph.2021.104931_bib24","first-page":"4102","article-title":"Scientific Opinion on the safety of caffeine","volume":"13","author":"EFSA","year":"2015","journal-title":"EFSA Journal"},{"key":"10.1016\/j.yrtph.2021.104931_bib25","author":"EMA"},{"issue":"2","key":"10.1016\/j.yrtph.2021.104931_bib26","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/toxsci\/kfy049","article-title":"Differentiating pathway-specific from nonspecific effects in high-throughput toxicity data: a foundation for prioritizing adverse outcome pathway development","volume":"163","author":"Fay","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2021.104931_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.fct.2014.10.017","article-title":"In vitro-to-in vivo correlation of the skin penetration, liver clearance and hepatotoxicity of caffeine","volume":"75","author":"Gajewska","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2021.104931_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jat.3730","article-title":"Comparison of the metabolism of 10 chemicals in human and pig skin explants","volume":"39","author":"G\u00e9ni\u00e8s","year":"2019","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2021.104931_bib29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/15287390490273550","article-title":"Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents","volume":"67","author":"Ginsberg","year":"2004","journal-title":"J. Toxicol. Environ. Health, Part A"},{"key":"10.1016\/j.yrtph.2021.104931_bib30","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.scitotenv.2017.07.258","article-title":"Estimation of caffeine intake from analysis of caffeine metabolites in wastewater","volume":"609","author":"Gracia-Lor","year":"2017","journal-title":"Sci. Total Environ."},{"issue":"3","key":"10.1016\/j.yrtph.2021.104931_bib31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jat.3913","article-title":"Measurement of the penetration of 56 cosmetic relevant chemicals into and through human skin using a standardised protocol","volume":"40","author":"Hewitt","year":"2020","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2021.104931_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/tera.1420310115","article-title":"Maternal toxicity: a possible etiological factor in embryo-fetal deaths and fetal malformations of rodent-rabbit species","volume":"31","author":"Khera","year":"1985","journal-title":"Teratology"},{"issue":"1","key":"10.1016\/j.yrtph.2021.104931_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/rtph.1996.1076","article-title":"A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data","volume":"25","author":"Klimisch","year":"1997","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/j.yrtph.2021.104931_bib34","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1021\/ci400649p","article-title":"Endocrine disruptome - an open source prediction tool for assessing endocrine disruption potential through nuclear receptor binding","volume":"54","author":"Kolsek","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.yrtph.2021.104931_bib35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s11095-016-2093-z","article-title":"Dodecyl amino glucoside enhances transdermal and topical drug delivery via reversible interaction with skin barrier lipids","volume":"34","author":"Kopecna","year":"2017","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"5","key":"10.1016\/j.yrtph.2021.104931_bib36","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1021\/js960440h","article-title":"Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolised drugs","volume":"86","author":"Lave","year":"1997","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.yrtph.2021.104931_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2125.1986.tb05246.x","article-title":"Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man","volume":"22","author":"Lelo","year":"1986","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.yrtph.2021.104931_bib38","doi-asserted-by":"crossref","first-page":"E586","DOI":"10.1152\/ajpendo.2001.281.3.E586","article-title":"Body surface area prediction in normal-weight and obese patients","volume":"281","author":"Livingston","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.yrtph.2021.104931_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2015.05.050","article-title":"Topical and transdermal delivery of caffeine","volume":"490","author":"Luo","year":"2015","journal-title":"Int. J. Pharmaceutics"},{"issue":"4","key":"10.1016\/j.yrtph.2021.104931_bib40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/0261192920965977","article-title":"A review of in silico tools as alternatives to animal testing: principles, resources and applications","volume":"48","author":"Madden","year":"2020","journal-title":"Altern Lab Anim"},{"key":"10.1016\/j.yrtph.2021.104931_bib41","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3390\/molecules21080974","article-title":"Structure-bioactivity relationships of methylxanthines: trying to make sense of all the promises and the drawbacks","volume":"21","author":"Monteiro","year":"2016","journal-title":"Molecules"},{"issue":"16","key":"10.1016\/j.yrtph.2021.104931_bib42","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1080\/10408398.2018.1461607","article-title":"Pharmacological potential of methylxanthines: retrospective analysis and future expectations","volume":"59","author":"Monteiro","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.yrtph.2021.104931_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.104746","article-title":"Application of physiologically based kinetic (PBK) modelling in the next generation risk assessment of dermally applied consumer products","volume":"63","author":"Moxon","year":"2020","journal-title":"Toxicol. Vitro"},{"issue":"200","key":"10.1016\/j.yrtph.2021.104931_bib44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-642-13443-2_6","article-title":"Xanthines as adenosine receptor antagonists","author":"M\u00fcller","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.yrtph.2021.104931_bib45","series-title":"Tech. Rep. No. 473, Theophylline. National Toxicology Program, US","author":"NTP","year":"1998"},{"issue":"Issue 11","key":"10.1016\/j.yrtph.2021.104931_bib46","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s002040050567","article-title":"Theophylline-induced mesenteric periarteritis in F344\/N rats","volume":"72","author":"Nyska","year":"1998","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2021.104931_bib47","series-title":"Theophylline, CAS 58-55-9","author":"OECD","year":"2001"},{"key":"10.1016\/j.yrtph.2021.104931_bib48","series-title":"Caffeine, CAS: 58-08-2","author":"OECD","year":"2002"},{"key":"10.1016\/j.yrtph.2021.104931_bib49","series-title":"Case Study on the Use of Integrated Approaches for Testing and Assessment for Systemic Toxicity Arising from Cosmetic Exposure to Caffeine","first-page":"321","author":"OECD","year":"2020"},{"key":"10.1016\/j.yrtph.2021.104931_bib50","series-title":"Guidance Document on the Characterisation, Validation and Reporting of PBK Models for Regulatory Purposes. Series on Testing and Assessment No. 331. ENV\/CBC\/MONO(2021)1","author":"OECD","year":"2021"},{"key":"10.1016\/j.yrtph.2021.104931_bib51","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2125.2007.03065.x","article-title":"The role of hair follicles in the percutaneous absorption of caffeine","volume":"65","author":"Otberg","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.yrtph.2021.104931_bib52","first-page":"61","article-title":"Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making","volume":"9","author":"Paini","year":"2019","journal-title":"Computational toxicology (Amsterdam, Netherlands)"},{"key":"10.1016\/j.yrtph.2021.104931_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105978","article-title":"Physiologically based kinetic (PBK) modelling and human biomonitoring data for mixture risk assessment","volume":"143","author":"Pletz","year":"2020","journal-title":"Environ. Int."},{"key":"10.1016\/j.yrtph.2021.104931_bib54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.comtox.2019.01.002","article-title":"An international effort to promote the regulatory use of PBK models based on non-animal data","volume":"11","author":"Sachana","year":"2019","journal-title":"Computational Toxicology"},{"issue":"3","key":"10.1016\/j.yrtph.2021.104931_bib55","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.yrtph.2015.05.017","article-title":"Use of an aggregate exposure model to estimate consumer exposure to fragrance ingredients in personal care and cosmetic products","volume":"72","author":"Safford","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2021.104931_bib56","series-title":"Notes of Guidance for the Testing of Cosmetic Ingredients and Their Safety Evaluation","author":"SCCS","year":"2021"},{"key":"10.1016\/j.yrtph.2021.104931_bib57","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.tiv.2007.09.010","article-title":"General approach for the calculation of tissue to plasma partition coefficients","volume":"22","author":"Schmitt","year":"2008","journal-title":"Toxicol. Vitro"},{"issue":"2","key":"10.1016\/j.yrtph.2021.104931_bib58","first-page":"1","article-title":"Case study with natural substances on the various options to identify and categorise endocrine disruptors","volume":"4","author":"Schuhmacher-Wolz","year":"2017","journal-title":"J. Toxicol. Health"},{"key":"10.1016\/j.yrtph.2021.104931_bib59","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.yrtph.2015.05.016","article-title":"A strategy for structuring and reporting a read-across prediction of toxicity","volume":"72","author":"Schultz","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2021.104931_bib60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1358\/mf.2000.22.2.796072","article-title":"Teratogenic and foetal toxicity following intravenous theophylline administration in pregnant rabbits is related to maternal drug plasma levels","volume":"22","author":"Shibata","year":"2000","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.yrtph.2021.104931_bib61","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/dmd.30.8.892","article-title":"Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method","volume":"30","author":"Shibata","year":"2002","journal-title":"Drug Metabol. Dispos."},{"issue":"Suppl. 1","key":"10.1016\/j.yrtph.2021.104931_bib62","first-page":"101","article-title":"Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine)","volume":"30","author":"Smetanova","year":"2009","journal-title":"Neuroendocrinol. Lett."},{"issue":"4","key":"10.1016\/j.yrtph.2021.104931_bib63","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/10408448209037495","article-title":"The toxicology of cocoa and methylxanthines: a review of the literature","volume":"9","author":"Tarka","year":"1982","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2021.104931_bib64","series-title":"GRAS Exemption Claim for Theobromine (3,7-dimethylxanthine), Summary of Data Concerning the Safety and GRAS Determination of Theobromine (3,7-dimethylxanthine) for Use as an Ingredient in Specified Foods","author":"Theocorp Holding Company","year":"2010"},{"key":"10.1016\/j.yrtph.2021.104931_bib65","series-title":"Effect of Repeat Application of [14C]-Caffeine on Percutaneous Absorption through Human Skin in Vitro. Poster, Occupational and Environmental Exposures of Skin to Chemicals","author":"Toner","year":"2009"},{"key":"10.1016\/j.yrtph.2021.104931_bib66","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.fct.2015.06.005","article-title":"Aggregate exposure modelling of zinc pyrithione in rinse-off personal cleansing products using a person-orientated approach with market share refinement","volume":"83","author":"Tozer","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2021.104931_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.05.057","article-title":"Aggregate exposure modelling of vitamin A from cosmetic products, diet and food supplements","volume":"131","author":"Tozer","year":"2019","journal-title":"Food Chem. Toxicol."},{"issue":"2","key":"10.1016\/j.yrtph.2021.104931_bib68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2125.2009.03463.x","article-title":"Permeation of topically applied caffeine through human skin \u2013 a comparison of in vivo and in vitro data","volume":"68","author":"Trauer","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.yrtph.2021.104931_bib69","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.yrtph.2015.07.012","article-title":"Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment","volume":"73","author":"Troutman","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2021.104931_bib70","series-title":"Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry","author":"United States Environmental Protection Agency (USEPA)","year":"1994"},{"key":"10.1016\/j.yrtph.2021.104931_bib71","series-title":"Approaches for the Application of Physiologically Based Pharmacokinetic (PBPK) Models and Supporting Data in Risk Assessment","author":"United States Environmental Protection Agency (USEPA)","year":"2006"},{"key":"10.1016\/j.yrtph.2021.104931_bib72","article-title":"Recommended use of body weight3\/4 as the default method in derivation of the oral reference dose","author":"United States Environmental Protection Agency (USEPA)","year":"2011","journal-title":"Risk Assessment Forum"},{"key":"10.1016\/j.yrtph.2021.104931_bib73","series-title":"Characterization and Application of Physiologically Based Pharmacokinetic Models in Risk Assessment","volume":"vol. 9","author":"WHO","year":"2010"},{"key":"10.1016\/j.yrtph.2021.104931_bib74","first-page":"59","article-title":"Effects of caffeine on health and nutrition: a Review","volume":"30","author":"Wolde","year":"2014","journal-title":"Food Sci. Qual. Manag."},{"key":"10.1016\/j.yrtph.2021.104931_bib75","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.yrtph.2009.09.006","article-title":"A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogues for SAR-based toxicological assessments","volume":"56","author":"Wu","year":"2010","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2021.104931_bib76","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/tera.1420340307","article-title":"Teratogenicity of paraxanthine (1,7\u2010dimethylxanthine) in C57BL\/6J mice","volume":"34","author":"York","year":"1986","journal-title":"Teratology"},{"issue":"3","key":"10.1016\/j.yrtph.2021.104931_bib77","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00418573","article-title":"The quantitative distribution of percutaneously applied caffeine in the human skin","volume":"266","author":"Zesch","year":"1979","journal-title":"Arch. Dermatol. Res."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230021000714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230021000714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:32:47Z","timestamp":1759494767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230021000714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":77,"alternative-id":["S0273230021000714"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2021.104931","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New framework for a non-animal approach adequately assures the safety of cosmetic ingredients \u2013 A case study on caffeine","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2021.104931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104931"}}